Live
- BJP slams Mehbooba Mufti for remark on Indus Water Treaty
- Global brokerage CLSA shifts ‘tactical allocation’ to India from China
- Istanbul nabs over 240 illegal migrants
- Haryana CM takes dig at Punjab counterpart on setting up of new legislative Assembly
- Avvatar India and Spartan Race Kick Off India’s Ultimate Fitness Challenge in Bengaluru
- CM Revanth Reddy Pays Tribute to Guru Nanak on His Birth Anniversary
- ‘Matka’ clears censor: run-time locked
- ‘Kubera’ first glimpse looks interesting
- It took me 20 years to reach Sahnkar sir’s ears: Thaman S
- Gaurav Bhatia slams Congress for promising freebies to infiltrators in Jharkhand
Natco Pharma launches Hepatitis B medicine
Highlights
Natco Pharma has launched a generic version of Tenofovir Alafenamide, a drug used for treating chronic Hepatitis B. The company in a communique to BSE, said that it’s one of the first entities to launch the generic version of the drug under its brand Tafnat.
Hyderabad: Natco Pharma has launched a generic version of Tenofovir Alafenamide, a drug used for treating chronic Hepatitis B. The company in a communique to BSE, said that it’s one of the first entities to launch the generic version of the drug under its brand Tafnat.
Natco is producing Tafnat under license from Medicines Patent Pool (MPP) and Gilead Sciences. The company has priced the medicine at Rs1,900 for a monthly pack of 30 tablets for the Indian market. Natco Pharma’s stock closed 1.3 per cent lower at Rs 1,007.35 on BSE.
Next Story
ADVERTISEMENT
